AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,057 Cr | ₹1,020 Cr | ₹738 Cr | ₹775 Cr | ₹459 Cr |
What is the latest Sundry Debtors ratio of AJANTA PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2023 | ₹1,057 Cr |
Mar2022 | ₹1,020 Cr |
Mar2021 | ₹738 Cr |
Mar2020 | ₹775 Cr |
Mar2019 | ₹459 Cr |
How is Sundry Debtors of AJANTA PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2023 | ₹1,057 Cr | 3.64 | |
Mar2022 | ₹1,020 Cr | 38.11 | |
Mar2021 | ₹738 Cr | -4.76 | |
Mar2020 | ₹775 Cr | 68.73 | |
Mar2019 | ₹459 Cr | - |
Compare Sundry Debtors of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹30,153.1 Cr | -1.8% | 15.2% | 87.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -1.8% |
15.2% |
87.7% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses